Pfizer's shares sag on earnings outlook

Article Abstract:

Pfizer Inc. posted an improvement in its net income for the first quarter of 1999. The company's results matched what had been forecasted by Wall Street. However, Pfizer's share value fell because the company surprisingly forecasted a "single-digit" growth in earnings for the second quarter of 1999. Pfizer posted an 18% rise in net income to $815 million for the period. This amounts to 62 cents a diluted share.

Comment:

Posts 18% improvement in its net income for the first quarter of 1999

Sales, profits & dividends, Pharmaceutical Preparation Manufacturing, Pharmaceutical Preparations, Drugs, Finance, Abstract, Pfizer Inc.

---

Merck's Board adopts separation-benefits plan

Article Abstract:

Merck and Co., pharmaceutical company, has awarded it's executives a golden severance package in case of a major acquisition or merger.

Pharmaceutical preparations, Personnel administration, Compensation and benefits, Merck & Company Inc.

---

Similar abstracts:

• Abstracts: Is Japan learning to smile? A costly battle against recession: Japan. Turning and turning
• Abstracts: Swiss airline sees shares surge 10%. More cooperation is sought in deal with British Airways. Airline decides not to acquire British Airways' Deutsche unit
• Abstracts: Dreams on the starting blocks. In a tailspin
• Abstracts: Legal eagles spread their wings. Japan Inc. pays
• Abstracts: Research on autopilot! Avoid push-button management

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.